4QFY13 net profit of RM166.9m (-3.5% qoq; +4.1% yoy) took FY13 to RM650m (+3.4% yoy), above our expectations (106.9%) but in line with consensus estimate (103.8%).
Mainly due to second highest quarterly provision write-back from significant jump in recovery (more than doubled qoq and almost doubled yoy) which more than offset provisions.
No more dividend as it has already paid 15 sen single-tier dividend or a payout of 35%, in line with our projection.
4QFY13 results were mainly boosted by provision writeback (mainly due to large recovery). Otherwise, it was a weak quarter despite continued loans growth due to NIM erosion (which resulted in net interest income lower qoq and yoy), lower qoq non-interest income (albeit higher yoy) and narrowing JAW.
FY13 also saw similar trend and would have shown a decline if not for the higher provision write-back.
Given that we do not expect the high recovery (and hence provision write-back) to continue indefinitely, we are only projecting a meager earnings growth in FY14 which translate into a ROE of 10%.
For FY14, the company has set ROE KPI of 9.2% (due to intention to raise RM1.25bn from right issue to fund the acquisition of Hwang IB. Recall that in our report dated 23 Jan 14, we estimated that the Hwang IB acquisition and the subsequent right issue will boost earnings by 2.7% but EPS will be diluted by 17.7% while ROE will reduce by circa 100bps. This implies that our FY14 forecasted 10% ROE would decline to 9% post rights issue, in line with its KPI of 9.2%.
Unexpected jump in impaired loans, lower than expected loan growth and intense competition from larger peers.
Post final results adjustments, FY14-15 raised by 0.7-2.3%.
HOLD
Positives
Negatives:
Following earnings forecasts adjustments, target price raised to RM4.26 based on Gordon Growth with ROE at 10% and WACC at 10.8% vs. RM4.10.
Source: Hong Leong Investment Bank Research - 27 Feb 2014
Chart | Stock Name | Last | Change | Volume |
---|